Followers | 839 |
Posts | 120456 |
Boards Moderated | 18 |
Alias Born | 09/05/2002 |
Monday, September 09, 2024 5:32:43 PM
https://www.sec.gov/Archives/edgar/data/1799448/000161071724000465/xslF345X05/form4.xml (CEO)
https://www.sec.gov/Archives/edgar/data/1799448/000161071724000466/xslF345X05/form4.xml (CFO)
https://www.sec.gov/Archives/edgar/data/1799448/000161071724000464/xslF345X05/form4.xml (CSO)
“The efficient-market hypothesis may be
the foremost piece of B.S. ever promulgated
in any area of human knowledge!”
Recent ALGS News
- Aligos Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) • GlobeNewswire Inc. • 09/13/2024 12:00:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 09/06/2024 08:22:44 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 09/05/2024 08:06:55 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 08/19/2024 08:05:59 PM
- Aligos Therapeutics Announces Reverse Stock Split • GlobeNewswire Inc. • 08/15/2024 01:00:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 08/09/2024 08:09:21 PM
- Form 3 - Initial statement of beneficial ownership of securities • Edgar (US Regulatory) • 08/09/2024 08:08:14 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 08/08/2024 08:11:01 PM
- Aligos Therapeutics Strengthens Board with Two New Independent Directors • GlobeNewswire Inc. • 08/08/2024 08:05:00 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/06/2024 08:14:20 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 08/06/2024 08:05:31 PM
- Aligos Therapeutics Reports Recent Business Progress and Second Quarter 2024 Financial Results • GlobeNewswire Inc. • 08/06/2024 08:05:00 PM
- Aligos Therapeutics to Announce 2nd Quarter 2024 Financial Results on August 6, 2024 • GlobeNewswire Inc. • 07/30/2024 08:05:00 PM
- Aligos Therapeutics Announces Clinical Collaboration with Xiamen Amoytop Biotech Co., Ltd. • GlobeNewswire Inc. • 07/22/2024 01:00:00 PM
- Aligos Therapeutics to Host KOL Event to Discuss the Positive Phase 1b Data from ALG-000184 for the Treatment of CHB • GlobeNewswire Inc. • 07/10/2024 12:00:00 PM
- Aligos Therapeutics Presents Positive Data at the EASL Congress 2024 • GlobeNewswire Inc. • 06/05/2024 06:30:00 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 05/31/2024 08:05:56 PM
- Aligos Therapeutics Announces Six Abstracts Accepted for Presentation at EASL 2024 • GlobeNewswire Inc. • 05/22/2024 08:05:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 05/22/2024 08:02:52 PM
- Aligos Therapeutics Announces the Completion of Enrollment in the ALG-055009 Phase 2a HERALD Study for the Treatment of MASH • GlobeNewswire Inc. • 05/21/2024 12:00:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 05/15/2024 09:01:03 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 05/07/2024 08:13:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 05/07/2024 08:05:32 PM
- Aligos Therapeutics Reports Recent Business Progress and First Quarter 2024 Financial Results • GlobeNewswire Inc. • 05/07/2024 08:05:00 PM
- Aligos Therapeutics to Announce 1st Quarter 2024 Financial Results on May 7, 2024 • GlobeNewswire Inc. • 04/30/2024 08:05:00 PM
FEATURED Mawson Finland Limited Further Expands the Known Mineralized Zones at Rajapalot: Palokas step-out drills 7 metres @ 9.1 g/t gold & 706 ppm cobalt • Sep 17, 2024 9:02 AM
PickleJar Announces Integration With OptCulture to Deliver Holistic Fan Experiences at Venue Point of Sale • PKLE • Sep 17, 2024 8:00 AM
North Bay Resources Announces Mt. Vernon Gold Mine Bulk Sample, Sierra County, California • NBRI • Sep 11, 2024 9:15 AM
One World Products Issues Shareholder Update Letter • OWPC • Sep 11, 2024 7:27 AM
Kona Gold Beverage Inc. Reports $1.225 Million in Revenue and $133,000 Net Profit for the Quarter • KGKG • Sep 10, 2024 1:30 PM
Element79 Gold Corp Announces 2024 Clover Work Plans & Nevada Portfolio Updates • ELMGF • Sep 10, 2024 11:00 AM